Literature DB >> 12214247

On the role of aurora-A in centrosome function.

Stéphanie Dutertre1, Simon Descamps, Claude Prigent.   

Abstract

Mammalian aurora-A belongs to a multigenic family of mitotic serine/threonine kinases comprising two other members: aurora-B and aurora-C. In this review we will focus on aurora-A that starts to localize to centrosomes only in S phase as soon as centrioles have been duplicated, the protein is then degraded in early G1. Works in various organisms have revealed that the kinase is involved in centrosome separation, duplication and maturation as well as in bipolar spindle assembly and stability. Aurora kinases are found in all organisms in which their function has been conserved throughout evolution, namely the control of chromosome segregation. In human, aurora-A has focused a lot of attention, since its overexpression has been found to be correlated with the grade of various solid tumours. Ectopic kinase overexpression in any culture cell line leads to polyploidy and centrosome amplification. However, overexpression of aurora-A in particular cell lines such as NIH3T3 is sufficient to induce growth on soft agar. Those transformed cells form tumours when implanted in immunodeficient mice, indicating that the kinase is an oncogene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214247     DOI: 10.1038/sj.onc.1205775

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  62 in total

1.  Suppression of Aurora-A oncogenic potential by c-Myc downregulation.

Authors:  Shangbin Yang; Shun He; Xiaobo Zhou; Mei Liu; Hongxia Zhu; Yihua Wang; Wei Zhang; Shuang Yan; Lanping Quan; Jingfeng Bai; Ningzhi Xu
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

2.  Characterization of plant Aurora kinases during mitosis.

Authors:  Akira Kawabe; Sachihiro Matsunaga; Katsuyuki Nakagawa; Daisuke Kurihara; Arata Yoneda; Seiichiro Hasezawa; Susumu Uchiyama; Kiichi Fukui
Journal:  Plant Mol Biol       Date:  2005-05       Impact factor: 4.076

3.  A small C-terminal sequence of Aurora B is responsible for localization and function.

Authors:  Laetitia Scrittori; Dimitrios A Skoufias; Fabienne Hans; Véronique Gerson; Paolo Sassone-Corsi; Stefan Dimitrov; Robert L Margolis
Journal:  Mol Biol Cell       Date:  2004-10-27       Impact factor: 4.138

Review 4.  Mitosis is not a key target of microtubule agents in patient tumors.

Authors:  Edina Komlodi-Pasztor; Dan Sackett; Julia Wilkerson; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2011-02-01       Impact factor: 66.675

5.  Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.

Authors:  Myriam Goldstein; Isaac Meller; Josephine Issakov; Avi Orr-Urtreger
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

6.  A microtubule-independent role for centrosomes and aurora a in nuclear envelope breakdown.

Authors:  Nathan Portier; Anjon Audhya; Paul S Maddox; Rebecca A Green; Alexander Dammermann; Arshad Desai; Karen Oegema
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

7.  Molecular distinctions between Aurora A and B: a single residue change transforms Aurora A into correctly localized and functional Aurora B.

Authors:  Fabienne Hans; Dimitrios A Skoufias; Stefan Dimitrov; Robert L Margolis
Journal:  Mol Biol Cell       Date:  2009-06-03       Impact factor: 4.138

Review 8.  Kinase signaling and targeted therapy for primary myelofibrosis.

Authors:  Qiong Yang; John D Crispino; Qiang Jeremy Wen
Journal:  Exp Hematol       Date:  2016-12-30       Impact factor: 3.084

9.  Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.

Authors:  M Orth; K Unger; U Schoetz; C Belka; K Lauber
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

Review 10.  Chromatin-modifying enzymes as therapeutic targets--Part 2.

Authors:  Brian R Keppler; Trevor K Archer
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.